Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Arcus Biosciences Inc
About RCUS
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company has a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Find out what a historical investment in Arcus Biosciences Inc would be worth today using our RCUS stock calculator.
Market Capitalisation
$2.86B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
797.38K
High today
$24.09
Low today
$23.02
Open price
$23.02
52-week high
$28.72
52-week low
$7.91
Ready to start your investing journey with Stake?
Open an accountHow do I buy RCUS shares in Australia?
Buying RCUS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arcus Biosciences Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RCUS
What is the ticker symbol of Arcus Biosciences Inc?
The ticker symbol for Arcus Biosciences Inc is RCUS.
How much is one share of RCUS?
One share of RCUS is valued at $23.75 as of 20 May 2026.
What is the market capitalisation of Arcus Biosciences Inc RCUS?
As of 20 May 2026 Arcus Biosciences Inc has a market cap of $2.86B.
What is the 52-week high for Arcus Biosciences Inc stock?
The Arcus Biosciences Inc 52-week high stock price is $28.72.
What is the 52-week low for Arcus Biosciences Inc stock?
The Arcus Biosciences Inc 52-week low stock price is $7.91.
Can I buy RCUS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RCUS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RCUS on Stake
- Buy RCUS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RCUS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RCUS related stocks